Sign In to View Pricing

Coronavirus

Status COVID-19/Flu A&B
Product Highlights
  • Sensitivity and Specificity: ? COVID-19 - Sensitivity 93.9%, Specificity 100%rn? Flu A - Sensitivity 91.4%, Specificity 95.7%rn? Flu B - Sensitivity 87.6%, Specificity 95.9%
  • FDA Emergency Use Authorization (EUA)
  • Visually read in 15 minutes
  • Flocked nasopharyngeal swab for superior specimen collection and patient comfort

Manufacturer: LifeSign
Item#: GRM33225
Status COVID-19/Flu A&B

Packaging:
25/BX
Unit of Measure:
Price:
Quantity:

Be the first to review this product


Product Description

A Rapid Immunoassay for the Simultaneous Direct Detection and Differential Diagnosis of SARS-CoV-2, Influenza Type A and Type B Antigen from nasopharyngeal swab specimens.

» Sensitivity and Specificity: ? COVID-19 - Sensitivity 93.9%, Specificity 100%rn? Flu A - Sensitivity 91.4%, Specificity 95.7%rn? Flu B - Sensitivity 87.6%, Specificity 95.9%

» FDA Emergency Use Authorization (EUA)

» Visually read in 15 minutes

» Flocked nasopharyngeal swab for superior specimen collection and patient comfort

Additional Information
Item Number GRM33225
Packaging 25/BX